BIOMAT Database Logo BIOMAT Database Logo

Combined FK 506 and mycophenolate mofetil immunosuppression prolongs survival after small bowel transplantation in pigs. 1996

M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Department of Surgery, University of Pavia School of Medicine, I.R.C.C.S. San Matteo Hospital, Italy.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
October 1996, Transplantation proceedings,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.
June 1998, Transplantation proceedings,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Synergistic effect of FK 506 and trifluoperazine on the immunosuppression in rat small bowel transplantation.
October 1996, Transplantation proceedings,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Insulin requirements after liver transplantation and FK-506 immunosuppression.
October 1993, Transplantation,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Kidney transplantation under FK 506 immunosuppression.
February 1991, Transplantation proceedings,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Clinical small bowel or small bowel plus liver transplantation under FK 506.
December 1991, Transplantation proceedings,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Canine total orthotopic small bowel transplantation under FK 506.
December 1991, Transplantation proceedings,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Pediatric renal transplantation under FK 506 immunosuppression.
December 1991, Transplantation proceedings,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Pediatric renal transplantation under FK-506 immunosuppression.
June 1992, The Journal of urology,
M Alessiani, and M Spada, and S Vaccarisi, and E Arbustini, and M Regazzi, and R Moratti, and G Bellinzona, and P Morbini, and P Dionigi, and A Zonta
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression.
June 1994, Transplantation proceedings,
Copied contents to your clipboard!